Chartwell Investment Partners’s Inspire Medical Systems INSP Stock Holding History

Chartwell Investment Partners’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,748	Closed	-$762K	–	430
2023 Q4	$762K	Sell	3,748 -1,680	-31%	-$272K	0.03%	383
2023 Q3	$1.08M	Sell	5,428 -648	-11%	-$163K	0.04%	348
2023 Q2	$1.97M	Buy	6,076 +2,833	+87%	+$809K	0.07%	281
2023 Q1	$759K	Buy	3,243 +108	+3%	+$27.3K	0.03%	366
2022 Q4	$790K	Buy	3,135 +179	+6%	+$38.2K	0.03%	364
2022 Q3	$525K	Buy	+2,956	New	+$594K	0.02%	385
2022 Q1	–	Sell	-5,728	Closed	-$1.32M	–	429
2021 Q4	$1.32M	Sell	5,728 -100	-2%	-$24.4K	0.04%	357
2021 Q3	$1.36M	Hold	5,828	–	–	0.04%	345
2021 Q2	$1.13M	Buy	+5,828	New	+$1.16M	0.03%	364

Other funds holding INSP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Chartwell Investment Partners's INSP Position: Q1 2024 in Review

Chartwell Investment Partners sold out of Inspire Medical Systems (INSP) in Q1 2024, closing a stake of 3,748 shares — an estimated $762K sold.

Chartwell Investment Partners first reported a position in INSP in Q2 2021 and held it in 9 quarters. The position peaked at $1.97M in Q2 2023. 328 funds tracked by Wall St. Rank hold INSP as of Q1 2024.

Chartwell Investment Partners reported no remaining Inspire Medical Systems position as of Q1 2024 after selling out during the quarter.
Chartwell Investment Partners sold 3,748 Inspire Medical Systems shares in Q1 2024, an estimated $762K.
Chartwell Investment Partners first reported a position in Inspire Medical Systems in Q2 2021 and held it in 9 quarters.
Chartwell Investment Partners's Inspire Medical Systems position peaked at $1.97M in Q2 2023.
328 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2024.

Based on Chartwell Investment Partners's 13F filing for Q1 2024, filed 14 May 2024.